Table 2.

List of endolysins in human clinical trials.

Endolysin	Study	Phase	Clinical Trials Identifier	Status
CF-301	Safety, Efficacy, and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. aureus Bacteremia	III	NCT04160468	Ongoing trial
N-Rephasin® SAL200 (Intron Biotechnology, Inc., South Korea)	To evaluate safety and to explore the efficacy of a single intravenous dose of N-Rephasin® SAL200 (3 mg/kg)	IIa	NCT03089697	Ongoing trial
P-128	Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients	II	NCT01746654	Completed